Referencias - Abbott Precision Xtra Manual Del Usuario

Referencias

1. Schade DS, Eaton RP. Metabolic and clinical significance
of ketosis. Special Topics in Endocrinology and Metabolism
1982; 4:1–27.
2. Wiggam MI, O'Kane MJ, Harper R, Atkinson AB, Hadden
DR, Trimble ER, Bell PM. Treatment of diabetic ketoacidosis
using normalization of blood 3-hydroxybutyrate
concentration as the endpoint of emergency
management. Diabetes Care 1997; 20:1347–52.
3. Harano Y, Kosugi K, Hyosu T, Suzuki M, Hidaka H, Kashiwagi A,
Uno S, Shigeta Y. Ketone bodies as markers for Type 1 (insulin-
dependent) diabetes and their value in the monitoring of
diabetes control. Diabetologia 1984; 26:343–8.
4. Ubukata E. Diurnal variation of blood ketone bodies in
insulin-dependent diabetes mellitus and non-insulin-
dependent diabetes mellitus patients: The relationship to
serum C-peptide immunoreactivity and free insulin. Ann
Nutr Metab 1990; 34:333–42.
5. Luzi L, Barrett EJ, Groop LC, Ferrannini E, DeFronzo RA.
Metabolic effects of low-dose insulin therapy on glucose
metabolism in diabetic ketoacidosis. Diabetes 1988;
37:1470–77.
6. Hale PJ, Crase J, Nattrass M. Metabolic effects of
bicarbonate in the treatment of diabetic ketoacidosis.
Br Med J 1984; 289; 1035–8.
55